Weight loss drugs are seen as an easy option for dropping the pounds, but they are also expensive, and can have nasty side ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

Novo Nordisk stock gains 3% as analysts at UBS upgrade the company's rating from Neutral to Buy based on strong brand ...

Up to 3.4 million eligible patients could benefit from the medication that treats type 2 diabetes and aids weight loss ...

Those in the jab trials, however, kept off between 10 and 25 per cent of their body weight over the same timeframe, depending ...

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

When Henry Conway hit his forties his BMI became dangerously high. After a lover said ‘I love your little dad bod’, he knew ...

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023. Lilly ...

“This approval enables access to the approved Mounjaro pen in a more convenient presentation of a month’s treatment, of one dose per week,” he added. It is to be used together with a reduced ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?